The complex interplay between insulin resistance and intestinal metabolism entails the regulation of multiple factors, and the underlying mechanisms remain to be further studied to gain new insights into the onset and progression of insulin resistance and devise new intervention strategies to improve insulin sensitivity and reduce the risk of metabolic disorders. The gene discussed is INS; the disease is Other metabolic disease.